Logo image of VMX.PA

VERIMATRIX SA (VMX.PA) Stock Fundamental Analysis

Europe - EPA:VMX - FR0010291245 - Common Stock

0.2 EUR
+0.01 (+4.17%)
Last: 9/25/2025, 4:28:28 PM
Fundamental Rating

1

Taking everything into account, VMX scores 1 out of 10 in our fundamental rating. VMX was compared to 107 industry peers in the Software industry. VMX may be in some trouble as it scores bad on both profitability and health. VMX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

VMX had negative earnings in the past year.
VMX had a positive operating cash flow in the past year.
In the past 5 years VMX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: VMX reported negative operating cash flow in multiple years.
VMX.PA Yearly Net Income VS EBIT VS OCF VS FCFVMX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

VMX's Return On Assets of -67.57% is on the low side compared to the rest of the industry. VMX is outperformed by 90.65% of its industry peers.
The Return On Equity of VMX (-149.99%) is worse than 87.85% of its industry peers.
Industry RankSector Rank
ROA -67.57%
ROE -149.99%
ROIC N/A
ROA(3y)-7.28%
ROA(5y)-4.86%
ROE(3y)-11.32%
ROE(5y)-7.72%
ROIC(3y)N/A
ROIC(5y)N/A
VMX.PA Yearly ROA, ROE, ROICVMX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

VMX has a Gross Margin of 66.57%. This is comparable to the rest of the industry: VMX outperforms 42.99% of its industry peers.
In the last couple of years the Gross Margin of VMX has declined.
The Profit Margin and Operating Margin are not available for VMX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.53%
GM growth 5Y-3.2%
VMX.PA Yearly Profit, Operating, Gross MarginsVMX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

VMX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VMX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, VMX has more shares outstanding
The debt/assets ratio for VMX has been reduced compared to a year ago.
VMX.PA Yearly Shares OutstandingVMX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
VMX.PA Yearly Total Debt VS Total AssetsVMX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that VMX is in the distress zone and has some risk of bankruptcy.
VMX has a worse Altman-Z score (-0.68) than 85.98% of its industry peers.
The Debt to FCF ratio of VMX is 36.72, which is on the high side as it means it would take VMX, 36.72 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 36.72, VMX is in line with its industry, outperforming 44.86% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that VMX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.28, VMX is in line with its industry, outperforming 52.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 36.72
Altman-Z -0.68
ROIC/WACCN/A
WACC7.29%
VMX.PA Yearly LT Debt VS Equity VS FCFVMX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

VMX has a Current Ratio of 0.83. This is a bad value and indicates that VMX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.83, VMX is doing worse than 74.77% of the companies in the same industry.
VMX has a Quick Ratio of 0.83. This is a bad value and indicates that VMX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.82, VMX is doing worse than 73.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.82
VMX.PA Yearly Current Assets VS Current LiabilitesVMX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The earnings per share for VMX have decreased strongly by -538.46% in the last year.
Looking at the last year, VMX shows a very negative growth in Revenue. The Revenue has decreased by -14.46% in the last year.
VMX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.24% yearly.
EPS 1Y (TTM)-538.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1420%
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.24%
Sales Q2Q%-13.99%

3.2 Future

VMX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.87% yearly.
VMX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.76% yearly.
EPS Next Y-700%
EPS Next 2Y7.24%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue Next Year-17.44%
Revenue Next 2Y-8.38%
Revenue Next 3Y-3.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VMX.PA Yearly Revenue VS EstimatesVMX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
VMX.PA Yearly EPS VS EstimatesVMX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VMX. In the last year negative earnings were reported.
Also next year VMX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VMX.PA Price Earnings VS Forward Price EarningsVMX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as VMX.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VMX indicates a somewhat cheap valuation: VMX is cheaper than 74.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.97
EV/EBITDA 21.81
VMX.PA Per share dataVMX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.24%
EPS Next 3Y11.87%

0

5. Dividend

5.1 Amount

No dividends for VMX!.
Industry RankSector Rank
Dividend Yield N/A

VERIMATRIX SA

EPA:VMX (9/25/2025, 4:28:28 PM)

0.2

+0.01 (+4.17%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-28 2025-07-28
Earnings (Next)10-22 2025-10-22
Inst Owners5.44%
Inst Owner ChangeN/A
Ins Owners2.39%
Ins Owner ChangeN/A
Market Cap17.51M
Analysts47.5
Price Target0.27 (35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-884.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.86%
Revenue NY rev (3m)-6.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF 22.97
P/OCF 6.69
P/B 0.44
P/tB N/A
EV/EBITDA 21.81
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.01
FCFY4.35%
OCF(TTM)0.03
OCFY14.94%
SpS0.51
BVpS0.46
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.57%
ROE -149.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.57%
FCFM 1.69%
ROA(3y)-7.28%
ROA(5y)-4.86%
ROE(3y)-11.32%
ROE(5y)-7.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.53%
GM growth 5Y-3.2%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 36.72
Debt/EBITDA 6.12
Cap/Depr 36.28%
Cap/Sales 4.12%
Interest Coverage N/A
Cash Conversion 141.62%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.82
Altman-Z -0.68
F-Score4
WACC7.29%
ROIC/WACCN/A
Cap/Depr(3y)35.24%
Cap/Depr(5y)53.33%
Cap/Sales(3y)4.63%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-538.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1420%
EPS Next Y-700%
EPS Next 2Y7.24%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.24%
Sales Q2Q%-13.99%
Revenue Next Year-17.44%
Revenue Next 2Y-8.38%
Revenue Next 3Y-3.76%
Revenue Next 5YN/A
EBIT growth 1Y16.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.88%
EBIT Next 3Y63.47%
EBIT Next 5YN/A
FCF growth 1Y-83.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.89%
OCF growth 3YN/A
OCF growth 5YN/A